Human Bird Flu Cases Spur Retail Trader Rush Into Vaccine Stocks [Yahoo! Finance]
CureVac N.V. - Ordinary Shares (CVAC)
Company Research
Source: Yahoo! Finance
It's a familiar setup for industry veterans who have witnessed past trading frenzies at the first signs of an outbreak. Most Read from Bloomberg These Flight Routes Suffer the World's Worst Turbulence Citi Trader Got 711 Warning Messages Before Sparking Flash Crash One Dead After Singapore Air Flight Hit By Severe Turbulence Barclays Managers Warn Some Staff to Prepare for Five Days a Week in Office Shares of CureVac NV, which has a bird-flu vaccine in early-stage testing, jumped 15% Wednesday as concerns grow over a potential outbreak of bird flu in humans following reports of a new case in Australia. Novavax Inc. — which recently touted its plans to explore an avian flu vaccine — gained for the third day closing at its highest level since December 2022. The shares of Covid shotmakers Moderna Inc. and BioNTech SE notched double-digit advances while Pfizer Inc. rose 3.7%. Read more: Just One Human Is Infected by Bird Flu. More US Cases Likely “Bird flu is adding mome
Show less
Read more
Impact Snapshot
Event Time:
CVAC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CVAC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CVAC alerts
High impacting CureVac N.V. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
CVAC
News
- CureVac Announces Voting Results of General MeetingAccesswire
- CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK [Yahoo! Finance]Yahoo! Finance
- CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSKAccesswire
- CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update Accesswire
- CureVac (NASDAQ: CVAC) was downgraded by analysts at Leerink Partnrs from an "outperform" rating to a "market perform" rating.MarketBeat
CVAC
Sec Filings
- 6/24/24 - Form 6-K
- 5/28/24 - Form 6-K
- 5/24/24 - Form 6-K
- CVAC's page on the SEC website